So, the good thing
is that you can buy stocks in every market cycle but you must be careful with
your investment spending.
Your final return depends in the end on your inital investment cost and if you buy at a high price, your return will fall into a low or negative area.
Good to know that dividends can upper your yield but my experience is that it could be very painful for an investor to look at a suffering return over years.
Your final return depends in the end on your inital investment cost and if you buy at a high price, your return will fall into a low or negative area.
Good to know that dividends can upper your yield but my experience is that it could be very painful for an investor to look at a suffering return over years.
These are my
criteria:
- Market Cap over
15 Billion
- Dividend Yield
in the higher yield space over 3 percent
- Cheapest
Enterprise-To-Ebitda Ratio on the market
My screen
delivered some interesting results in the large cap area: Oil companies are
top.
COP, CVX are the
best results in terms of EV/EBITDA. Both have a ratio of around 5 which is very
comfortable in the current situation but what about Russia and the Middle East
crises?
My second best
results came from the technology space: Intel and Verizon. Warren Buffett added
his VZ stake by one third on the past quarter and he might be right because VZ
is much cheaper than rival AT&T. The EV/EBITDA ratio is only at 6.35 while
T has a ratio of 9.66.
Healthcare is also good positioned
with Merck, Pfizer and Eli Lilly but those are suffering on the patent cliff.
I believe that it
does not make sense to look at stocks with a higher ratio. For sure cash flows
can come down and the full sheet becomes trash but most of the companies serve
values. What are your thoughts about my current screen? How are you invested?
These are the best results in terms of lowest debt-to-equity ratio:
ConocoPhillips (NYSE:COP) has a market capitalization of $98.66 billion. The company employs 19,200 people, generates revenue of $56.185 billion and has a net income of $8.037 billion. ConocoPhillips’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $20.761 billion. The EBITDA margin is 36.95 percent (the operating margin is 22.78 percent and the net profit margin 14.30 percent).
ConocoPhillips (NYSE:COP) has a market capitalization of $98.66 billion. The company employs 19,200 people, generates revenue of $56.185 billion and has a net income of $8.037 billion. ConocoPhillips’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $20.761 billion. The EBITDA margin is 36.95 percent (the operating margin is 22.78 percent and the net profit margin 14.30 percent).
Financial Analysis: The total debt represents 18.35 percent of ConocoPhillips’s assets and the total debt in relation to the equity amounts to 41.59 percent. Due to the financial situation, a return on equity of 15.94 percent was realized by ConocoPhillips. Twelve trailing months earnings per share reached a value of $6.49. Last fiscal year, ConocoPhillips paid $2.70 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.36, the P/S ratio is 1.77 and the P/B ratio is finally 1.91. The dividend yield amounts to 3.61 percent and the beta ratio has a value of 1.01.
 |
| Long-Term Stock Price Chart Of ConocoPhillips (COP) |
 |
| Long-Term Dividend Payment History of ConocoPhillips (COP) |
 |
| Long-Term Dividend Yield History of ConocoPhillips (COP) |
If you would like to receive more dividend stock ideas, you should subscribe to my free e-mail list.
Alternatively, you can follow me on Facebook or Twitter.
Pfizer (NYSE:PFE) has a market capitalization of $183.38 billion. The company employs 77,700 people, generates revenue of $51.584 billion and has a net income of $11.410 billion. Pfizer’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $23.623 billion. The EBITDA margin is 45.80 percent (the operating margin is 31.32 percent and the net profit margin 22.12 percent).
Financial Analysis: The total debt represents 21.20 percent of Pfizer’s assets and the total debt in relation to the equity amounts to 47.82 percent. Due to the financial situation, a return on equity of 14.45 percent was realized by Pfizer. Twelve trailing months earnings per share reached a value of $1.59. Last fiscal year, Pfizer paid $0.96 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 18.24, the P/S ratio is 3.54 and the P/B ratio is finally 2.42. The dividend yield amounts to 3.61 percent and the beta ratio has a value of 0.68.
 |
| Long-Term Stock Price Chart Of Pfizer (PFE) |
 |
| Long-Term Dividend Payment History of Pfizer (PFE) |
 |
| Long-Term Dividend Yield History of Pfizer (PFE) |
Chevron (NYSE:CVX) has a market capitalization of $241.37 billion. The company employs 64,600 people, generates revenue of $220.264 billion and has a net income of $21.597 billion. Chevron’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $41.912 billion. The EBITDA margin is 19.03 percent (the operating margin is 12.59 percent and the net profit margin 9.81 percent).
Financial Analysis: The total debt represents 8.05 percent of Chevron’s assets and the total debt in relation to the equity amounts to 13.70 percent. Due to the financial situation, a return on equity of 15.00 percent was realized by Chevron. Twelve trailing months earnings per share reached a value of $10.48. Last fiscal year, Chevron paid $3.90 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.13, the P/S ratio is 1.10 and the P/B ratio is finally 1.64. The dividend yield amounts to 3.35 percent and the beta ratio has a value of 1.08.
 |
| Long-Term Stock Price Chart Of Chevron (CVX) |
 |
| Long-Term Dividend Payment History of Chevron (CVX) |
 |
| Long-Term Dividend Yield History of Chevron (CVX) |
If you would like to receive more dividend stock ideas, you should subscribe to my free e-mail list. Alternatively, you can follow me on Facebook or Twitter.
Financial Analysis: The total debt represents 23.72 percent of Merck’s assets and the total debt in relation to the equity amounts to 50.36 percent. Due to the financial situation, a return on equity of 8.57 percent was realized by Merck. Twelve trailing months earnings per share reached a value of $1.90. Last fiscal year, Merck paid $1.72 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 31.19, the P/S ratio is 3.86 and the P/B ratio is finally 3.46. The dividend yield amounts to 2.99 percent and the beta ratio has a value of 0.40.
 |
| Long-Term Stock Price Chart Of Merck (MRK) |
 |
| Long-Term Dividend Payment History of Merck (MRK) |
 |
| Long-Term Dividend Yield History of Merck (MRK) |
Eli Lilly (NYSE:LLY) has a market capitalization of $69.63 billion. The company employs 39,235 people, generates revenue of $23.113 billion and has a net income of $4.684 billion. Eli Lilly’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6.877 billion. The EBITDA margin is 29.76 percent (the operating margin is 23.24 percent and the net profit margin 20.27 percent).
Financial Analysis: The total debt represents 14.79 percent of Eli Lilly’s assets and the total debt in relation to the equity amounts to 29.57 percent. Due to the financial situation, a return on equity of 28.92 percent was realized by Eli Lilly. Twelve trailing months earnings per share reached a value of $3.14. Last fiscal year, Eli Lilly paid $1.96 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 19.83, the P/S ratio is 3.00 and the P/B ratio is finally 3.93. The dividend yield amounts to 3.16 percent and the beta ratio has a value of 0.45.
 |
| Long-Term Stock Price Chart Of Eli Lilly (LLY) |
 |
| Long-Term Dividend Payment History of Eli Lilly (LLY) |
 |
| Long-Term Dividend Yield History of Eli Lilly (LLY) |
 |
| 1-Year Performance (Click to enlarge) |
 |
| Screener Results (Click to enlarge) |
Do you like this article? If yes, please support us and hit the button for a Facebook Like, make a tweet or post a comment in the Dividend Yield
community! Thank you so much, we really appreciate it.
------------
Related Stock Ticker Symbols:
PFE, COP, CVX, LLY, MRK
*I am long INTC, . I receive
no compensation to write about these specific stocks, sector or theme. I don't
plan to increase or decrease positions or obligations within the next 72 hours.
For the other stocks: I
have no positions in any stocks mentioned, and no plans to initiate any
positions within the next 72 hours. I receive no compensation to write about
any specific stock, sector or theme.